Alcohol-Related Liver Disease References

Last updated: 08 August 2024
  1. Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol. 2002 Apr;36(4):480-487. PMID: 11943418
  2. Arteel G, Marsano L, Mendez C, et al. Advances in alcoholic liver disease. Best Pract Clin Gastroenterol. 2003;17(4):625-647. PMID: 12828959
  3. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterolology. Am J Gastroenterol. 1998 Nov;93(11):2022-2036. PMID: 9820369
  4. Jamal MM, Morgan TR. Liver disease in alcohol and hepatitis C. Best Pract Clin Gastroenterol. 2003;17(4):649-662. PMID: 12828960
  5. Stewart SF, Day CP. The management of alcoholic liver disease. J Hepatol. 2003;38(Suppl 1):S2-S13. PMID: 12591182
  6. Maher J. Alcoholic Liver Disease. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management. 7th ed. Pennsylvania: Saunders; 2002:1375-1391
  7. MedWormhttp://www.medworm.com/rss/index.php/Gastroenterology/17/http://www.medworm.com/rss/medicalfeeds/specialities/Gastroenterology.xml
  8. European Association for the Study of the Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012 Aug;57(2):399-420. http://www.easl.eu/assets/application/files/5e1b5512fb2cabb_file.pdf. Accessed 20 Feb 2014. PMID: 22633836
  9. O'Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology. 2010 Jan;51(1):307-328. https://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/AlcoholicLiverDisease1-2010.pdf. Accessed 20 Feb 2014. PMID: 20034030
  10. Luo SH, Chu JG, Huang H, et al. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World J Clin Cases. 2019 Jul 6;7(13):1599-1610. doi: 10.12998/wjcc.v7.i13.1599. PMID: 31367619
  11. Shah NJ, Royer A, Savio J. Alcoholic hepatitis. StatPearls. https://www.ncbi.nlm.nih.gov. 18 Jun 2021.
  12. Babor TF, Higgins-Biddle JC, Saunders JB, et al. AUDIT. The Alcohol Use Disorders Identification Test. Guidelines for use in primary care. 2nd ed. 2001. https://www.paho.org.
  13. John B, Newstead S, Heirene R, et al. Does the Fast Alcohol Screening Test accurately distinguish between harmful and severely dependent tiers of alcohol misuse?. Alcohol Alcohol. 2021 Nov;56(6):737–745. doi: 10.1093/alcalc/agab015. Accessed 14 Sep 2023. PMID: 33754640
  14. National Institute of Health and Care Excellence (NICE). Alcohol-use disorders: prevention. NICE. https://www.nice.org.uk. 02 Jun 2010.
  15. National Institute on Alcohol Abuse and Alcoholism (NIAAA). The healthcare professional's core resource on alcohol. NIAAA. https://www.niaaa.nih.gov. 29 Jun 2023.
  16. Sachdeva A, Choudhary M, Chandra M. Alcohol withdrawal syndrome: benzodiazepines and beyond. J Clin Diagn Res. 2015 Sep;9(9):VE01–VE07. doi: 10.7860/JCDR/2015/13407.6538. PMID: 26500991
  17. Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on a new fatty liver disease nomenclature. Hepatology. 2023 Jun. doi: 10.1097/HEP.0000000000000520. Accessed 14 Jul 2023. PMID: 37363821
  18. Gallego-Durán R, Albillos A, Ampuero J, et al. Metabolic-associated fatty liver disease: from simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterol Hepatol. 2022 Nov;45(9):724-734. doi: 10.1016/j.gastrohep.2022.02.005. Accessed 23 Jun 2023. PMID: 35248669
  19. Eslam M, Sarin SK, Wong VWS, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020 Dec;14(6):889-919. doi: 10.1007/s12072-020-10094-2. Accessed 23 Jun 2023. PMID: 33006093
  20. Stickel F, Datz C, Hampe J, et al. Pathophysiology and management of alcoholic liver disease: update 2016. Gut Liver. 2017 Mar;11(2):173-188. doi: 10.5009/gnl16477. PMID: 28274107
  21. Friedman SL. Pathogenesis of alcohol-associated liver disease. UpToDate. https://www.uptodate.com. 31 Jan 2022.
  22. Friedman SL. Management of alcohol-associated steatosis and alcohol-associated cirrhosis. UpToDate. https://www.uptodate.com. 19 Apr 2022.
  23. Friedman SL. Management and prognosis of alcoholic hepatitis. UpToDate. https://www.uptodate.com. 17 May 2022.
  24. Friedman SL. Clinical manifestations and diagnosis of alcohol-associated fatty liver disease and cirrhosis. UpToDate. https://www.uptodate.com. 01 May 2023.
  25. Friedman SL. Alcoholic hepatitis: clinical manifestations and diagnosis. UpToDate. https://www.uptodate.com. 29 Jul 2022.
  26. Cabezas J. Management of alcohol-related liver disease and its complications. Clin Drug Investig. 2022 Jun;42(Suppl 1):47-53. doi: 10.1007/s40261-022-01143-9. PMID: 35467296
  27. Singal AK, Bataller R, Ahn J, et al. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018 Feb;113(2):175-194. doi: 10.1038/ajg.2017.469. Accessed 29 May 2018. PMID: 29336434
  28. European Association for the Study of the Liver (EASL). EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018 Jul;69(1):154-181. doi: 10.1016/j.jhep.2018.03.018. Accessed 16 Jan 2020. PMID: 29628280
  29. Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-333. doi: 10.1002/hep.30866. Accessed 16 Jan 2020. PMID: 31314133
  30. Friedman SL. Prognosis and management of alcoholic fatty liver disease and alcoholic cirrhosis. UpToDate. https://www.uptodate.com/. 25 Feb 2014.